NCT01377467View on ClinicalTrials.gov

Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

May 31, 2015

Study Completion Date

October 31, 2015

Conditions
OsteoporosisChronic Kidney Disease
Interventions
DRUG

Denosumab (Prolia)

60 mg s.c. injection at baseline and after 6 months

Trial Locations (1)

8091

Division of Nephrology, University Hospital, Zurich

All Listed Sponsors
lead

Rudolf Wuethrich

OTHER

NCT01377467 - Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients | Biotech Hunter | Biotech Hunter